Takeda - Recruiting 20 years or older. - A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R.
HanAll BioPharma Co., Ltd. - Recruiting 18 years to 80 years. - A Phase 3, Randomized, Double- Blind, Multi-center, Double Dummy, Clinical Trial Comparing HL-040XC With Single Component Therapies(Atorvastatin, Losartan) to Assess the Efficacy and Safety of HL-040XC in Patients With Essential Hypertension and Hyperlipidemia.
PhaseBio Pharmaceuticals Inc. - Recruiting 18 years to 80 years. - Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of VasomeraT (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension.
Placebo Single IV (Intravenous) Infusion; Experimental: Single IV Infusion Vasomera (PB1046)
University of Pavia - Recruiting 18 years to 65 years. - Randomized, Controlled, Parallel Arm, PROBE Study to Evaluate Different Effects of Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension.
Jeil Pharmaceutical Co., Ltd. - Recruiting 18 years to 75 years. - A 8-Week, Randomized, Double-Blind, Parallel Designed, Phase II Multi-Center Clinical Trial to Evaluate the Antihypertensive Efficacy and the Safety of OJP-2028 Tablets in Patients With the Uncomplicated Essential Hypertension.
Tokyo University - Recruiting 40 years to 80 years. - ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-Dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment.